Waist-to-Height Ratio Predicts Liver Steatosis and Fibrosis
By Lori Solomon HealthDay Reporter
WEDNESDAY, June 18, 2025 -- Waist-to-height ratio (WHtR) outperforms body mass index (BMI) in detecting the risk for liver disease, according to a study published in the July issue of the Journal of the Endocrine Society.
Andrew O. Agbaje, M.D., M.P.H., Ph.D., from University of Eastern Finland in Kuopio, examined whether new WHtR cut points predict liver steatosis and fibrosis. The analysis included data from 6,464 multiracial U.S. adults participating in the National Health and Nutrition Examination Survey (2021 to 2023).
Agbaje found that adjusted WHtR high fat mass predicted liver steatosis (odds ratio [OR], 1.63) and fibrosis (OR, 1.31). Similarly, excess WHtR fat mass was associated with liver steatosis (OR, 4.02) and fibrosis (OR, 1.61), while normal WHtR fat mass predicted lower odds of liver steatosis (OR, 0.52) and fibrosis/cirrhosis (OR, 0.48). Separately, WHtR high fat mass and excess fat mass predicted higher odds of liver steatosis better than BMI-overweight and BMI-obesity (1.6-fold and 6.0-fold, respectively).
“Remarkably, the findings were consistent regardless of sex and age. In addition, the findings were similar across the studied White, Black, Mexican-American, and Hispanic populations," Agbaje said in a statement. "The simple and universally accessible waist-to-height measurement is useful in clinical and public health practice for liver disease screening, prevention, diagnosis and management globally."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 -- Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and cardiovascular disease (CVD)...
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
THURSDAY, July 10, 2025 -- Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels, according...
Majority of Patients With Lyme Disease Do Not Follow Up With Clinician
THURSDAY, July 10, 2025 -- Only 34 percent of patients with erythema migrans >5 cm are positive for Lyme disease by a standard two-tier testing (STTT) algorithm, and of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.